Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,857

Document Document Title
WO/2021/069927A1
The disclosures herein relate to novel compounds of formula (1): (1) and salts thereof, wherein A, X, R1, R2, R3, R4, R10 and R11 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk o...  
WO/2021/055849A1
The application relates to lipids of Formula (A-1) and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include such a lipid as well as additional lipids such as phospholipids, structural lipids, and...  
WO/2021/025918A3
Provided herein are heterogeneous catalysts suitable for use in carbonylation reactions, including the production of acrylic acid from ethylene oxide and carbon monoxide on an industrial scale. The production may involve various unit ope...  
WO/2021/029362A1
The present disclosure provides a composition for improving the conductivity of a conductive component or conductive material, the composition comprising the compound represented by formula (4). The present disclosure further provides a ...  
WO/2021/020429A1
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.  
WO/2021/021384A1
A process for oxidizing iso-butane with oxygen to produce t-butyl hydroperoxide and t-butyl alcohol; dehydrating at least a portion of the t-butyl alcohol to produce di-tert-butyl ether and isobutylene; epoxidizing at least a portion of ...  
WO/2021/009026A1
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...  
WO/2021/007661A1
The current application relates to cannabinoid derivatives of formula (I) and pharmaceutical compositions comprising the same. The cannabinoid derivative can be used for the treatment of diseases associated with cannabinoid receptor such...  
WO/2021/009568A1
Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and f...  
WO/2021/007663A1
This disclosure relates to cannabinoid derivatives of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives in treating or preventing a diseases associated with a cannabinoid receptor ...  
WO/2020/253839A1
The present invention relates to a compound represented by formula (I), wherein variables n, m, z, p, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the description. The compound represented by formula (I) not only has, after photoc...  
WO/2020/249507A1
An anhydrous, crystalline form of Cabazitaxel [Form (H-1)] is herein disclosed. Form H-1 shows a13C SS-NMR spectrum featuring one single polymorph and showing the same advantages as known form H with respect to known Form D in terms of s...  
WO/2020/249473A1
The invention relates to a process for the carbonylation of epoxides in the presence of catalyst systems, wherein the carbonylation takes place in the presence of carbon monoxide, and wherein the catalyst system contains a molybdenum-bas...  
WO/2020/239980A1
The present invention relates to an arthropod controlling composition comprising a compound according to formula (I), methods and uses to control arthropods as well as arthropod controlling articles comprising the same.  
WO/2020/243754A1
Provided herein is a method of forming a beta-lactone from a carboxylic acid having a beta-carbon with a hydrogen atom disposed thereon. The method comprises contacting a carboxylic acid of formula (1) as described herein with an effecti...  
WO/2020/223813A1
There is described herein a nanoparticle comprising an outer shell comprising a porphyrin salt, an expanded porphyrin salt or an analog of porphyrin salt, around an inner oil core.  
WO/2020/222010A1
The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein R A, R B, R C and R D are as defined herein.  
WO/2020/194237A1
Methods of rapidly inhibiting efflux from a cell, sensitizing a drug-resistant cell to a drug and treating a subject with a drug-resistant pathology, by administering tetrahydrocannabinolic acid (THCa), cannabidiol (CBD) or a combination...  
WO/2020/185420A1
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.  
WO/2020/177748A1
The present invention relates to the technical field of medicines, and specifically disclosed are a quaternized modified taxane derivative, a pharmaceutical composition, and a synthetic pathway and use thereof. The taxane derivative is p...  
WO/2020/156307A1
The present invention relates to the technical field of pharmacy, relates to a lymphatic mediated transport-based triglyceride prodrug, and specifically relates to a triglyceride prodrug of different joining chains in a lymphatic mediate...  
WO/2020/144297A1
The present invention concerns nanoemulsions encapsulating a prodrug and bearing a targeting ligand, said nanoemulsion being formed by a natural oil and/or a synthetic oil and an amphiphilic surfactant, the methods for preparing these na...  
WO/2020/135427A1
The present invention relates to a monomer compound represented by formula (I), wherein each variable is as defined in the description. The described monomer is quickly synthesized at a high yield by means of a click chemistry reaction b...  
WO/2020/139001A1
The present invention provides a novel aryl-substituted aminomethyloxetenyl amino alcohol derivative or a pharmaceutically acceptable salt thereof. More specifically, the derivative has an effect of promoting ATP production and as such, ...  
WO/2020/107078A1
Provided herein is a dendrimer comprising: i) a core unit (C); and ii) building units (BU), wherein the core unit is covalently attached to at least two building units; the dendrimer having from two to six generations of building units; ...  
WO/2020/104822A1
The present invention relates to a compound of formula (Ia), or a pharmaceutically acceptable salt or hydrate thereof, wherein: the group X-Y is -NHSO2- or -SO2NH-; R1 is H or alkyl; R2 is selected from COOH and a tetrazolyl group; R3 is...  
WO/2020/097739A1
Provided herein are nanoparticles including self-assembled cellular components derived from a homogenized plant tissue. Also provided are food powders and other related compositions. Methods for preparing such nanoparticles and food powd...  
WO/2020/078421A1
A monomer compound of formula (I) and a method for preparing the monomer. Each variable is as defined in the description. According to the present monomer, by means of a click chemistry reaction between thiol and olefin, a perfluorinated...  
WO/2020/078423A1
A monomeric compound of formula (I), wherein variables are as defined in the specification. The monomer is synthesized in high yield and fast by means of click chemistry reaction between mercaptan and alkene, and a basically perfluorinat...  
WO/2020/078422A1
Provided is the monomer compound of formula (I), the variables thereof being as defined in the description. The monomer is synthesized at high yield and quickly by means of a click chemistry reaction between a thiol and an olefin; furthe...  
WO/2020/039092A3
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haemat...  
WO/2020/039088A3
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haemat...  
WO/2020/039092A2
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haemat...  
WO/2020/039088A2
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haemat...  
WO/2020/033248A1
The present invention is directed to processes for producing beta-lactone and beta-lactone derivatives using heterogenous catalysts. In preferred embodiments of the present invention, the processes comprise: passing a feed stream compris...  
WO/2020/027150A1
A compound represented by general formula (I) (wherein each symbol is as defined in the description) or a salt thereof has a potent neural protecting and/or repairing effect and, therefore, is usable as a therapeutic agent for neurologic...  
WO/2020/014750A1
Provided herein are dendrimers comprising: a core unit, five generations of building units which are lysine residues or analogues thereof, first terminal groups comprising a cabazitazel residue covalently attached to a diglycolyl linker ...  
WO/2020/016427A1
The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection an...  
WO/2020/011062A1
Provided are an epoxy modified acrylic resin and a preparation method therefor, and an energy-curable composition containing epoxy modified acrylic resin and application. A branched chain of at least one repeat unit in the acrylic resin ...  
WO/2020/005935A1
This invention provides compounds that modulate glucose uptake activity and cellular transport/uptake of glucose, and particularly GLUTS3, but also including but not limited to GLUT1-14 (SLC2A1-SLC2A14). Compounds of the invention are us...  
WO/2019/242691A1
Provided are a paclitaxel-lipid-polysaccharide dual-type conjugate related to general formula I, a preparation method therefor, a use thereof, and a pharmaceutical composition comprising same. The present invention also relates to a seri...  
WO/2019/228994A1
This invention relates to oleic acid derivative comprising a hydrophobic part C17H33 linked to a particular polar head part "A", especially for use as a medicament, for instance, for the treatment of a disorder caused by the GPR120 recep...  
WO/2019/226490A1
Provided is a compound of Formula (I), wherein the variable groups are defined herein.  
WO/2019/221925A1
Provided herein are integrated systems and processes for more efficient use of raw materials in chemical synthesis of ammonia, urea and copolymers. The systems and processes may include nutrient fermentation, carbonylation of syngas deri...  
WO/2019/206156A1
The present invention provides pharmaceutically acceptable salts of a benzodicycloalkane derivative, a polymorphic substance thereof, and an application thereof. Specifically, the present invention provides a benzodicycloalkane derivativ...  
WO/2019/170092A1
The present invention provides a ketone carbonyl-containing hydrophobic antitumor drug and a conjugate thereof as well as a nano preparation containing the conjugate, a preparation method therefor, and an application thereof. The conjuga...  
WO/2019/148282A1
The present disclosure concerns methods and formulations for delivery of hydrophobic agents (such as ubiquinone or poorly soluble drugs) for therapeutic and bioanalytical use. It further concerns use of lipopeptides (e.g. caspofungin) or...  
WO/2019/143220A1
The present invention relates to a transition metal-based heterogeneous carbonylation reaction catalyst, which has excellent catalyst activity and selectivity in a carbonylation reaction by polymerizing transition metal-based heterogeneo...  
WO/2019/124345A1
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that satisfies the demand for the high-speed response, low-voltage drive, high contrast, long-term reliability, and the like that have h...  
WO/2019/110427A1
Compounds of the formula (I) wherein the subsitiuents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and t...  

Matches 1 - 50 out of 2,857